Citadel Advisors - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 74 filers reported holding NEVRO CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$8,697,434
-1.1%
452,520
+30.8%
0.00%0.0%
Q2 2023$8,795,269
-43.7%
345,998
-20.0%
0.00%
-66.7%
Q1 2023$15,627,284
-13.0%
432,290
-4.7%
0.00%
-25.0%
Q4 2022$17,953,650
+18.5%
453,375
+39.4%
0.00%
+33.3%
Q3 2022$15,154,000
-1.8%
325,203
-7.6%
0.00%
-25.0%
Q2 2022$15,433,000
+31.0%
352,102
+116.2%
0.00%
+100.0%
Q1 2022$11,782,000
+66.2%
162,897
+86.3%
0.00%
+100.0%
Q4 2021$7,090,000
-87.8%
87,459
-82.5%
0.00%
-91.7%
Q3 2021$58,189,000
+902.9%
499,982
+1328.5%
0.01%
+1100.0%
Q2 2021$5,802,000
-85.8%
35,000
-88.1%
0.00%
-88.9%
Q1 2021$40,982,000
-30.3%
293,774
-13.5%
0.01%
-40.0%
Q4 2020$58,764,000
+89.8%
339,478
+52.7%
0.02%
+66.7%
Q3 2020$30,966,000
+126.6%
222,297
+94.4%
0.01%
+50.0%
Q2 2020$13,663,000
+10.7%
114,361
-7.3%
0.01%0.0%
Q1 2020$12,338,000
-84.6%
123,398
-81.9%
0.01%
-82.9%
Q4 2019$79,961,000
-2.8%
680,289
-28.9%
0.04%
-7.9%
Q3 2019$82,230,000
+141.3%
956,502
+82.0%
0.04%
+137.5%
Q2 2019$34,071,000
+2.9%
525,546
-0.8%
0.02%0.0%
Q1 2019$33,114,000
-20.6%
529,760
-50.6%
0.02%
-33.3%
Q4 2018$41,712,000
+111.8%
1,072,576
+210.5%
0.02%
+166.7%
Q3 2018$19,691,000
+490.6%
345,454
+727.3%
0.01%
+800.0%
Q2 2018$3,334,000
+14.9%
41,759
+24.7%
0.00%0.0%
Q1 2018$2,902,000
-79.1%
33,488
-83.4%
0.00%
-88.9%
Q4 2017$13,914,000
-85.8%
201,534
-81.3%
0.01%
-88.0%
Q3 2017$98,003,000
+17.6%
1,078,385
-3.7%
0.08%
+7.1%
Q2 2017$83,324,000
+65.1%
1,119,509
+107.9%
0.07%
+52.2%
Q1 2017$50,466,000
+200.4%
538,605
+133.0%
0.05%
+170.6%
Q4 2016$16,800,000
-55.5%
231,206
-36.1%
0.02%
-56.4%
Q3 2016$37,754,000
-30.3%
361,660
-50.8%
0.04%
-35.0%
Q2 2016$54,185,000
+68.4%
734,612
+28.4%
0.06%
+46.3%
Q1 2016$32,181,000
-41.1%
572,008
-29.3%
0.04%
-31.7%
Q4 2015$54,604,000
+235.3%
808,839
+130.4%
0.06%
+300.0%
Q3 2015$16,283,000
+2291.0%
350,984
+2370.7%
0.02%
+1400.0%
Q1 2015$681,000
+179.1%
14,206
+125.3%
0.00%
Q4 2014$244,0006,3040.00%
Other shareholders
NEVRO CORP shareholders Q4 2014
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders